Info
Insider Ownership

Insider Trading & Ownership of Joshua A. Kazam

Location: New York, NY
Summary: The estimated net worth of Joshua A. Kazam is at least $459,499 dollars as of 22 Dec 2025. Joshua A. Kazam is the Director of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $459.5K.
Signature: /s/Earl Douglas, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Joshua A. Kazam files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Joshua A. Kazam

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ALLO	Allogene Therapeutics, Inc.	Director	$459,499			18 Dec 2025
KRON	Kronos Bio, Inc.	Director	$0			20 Jun 2025
SCRM	Screaming Eagle Acquisition Corp.	Director				05 Jan 2022
LTCH	TS Innovation Acquisitions Corp.	Former Director				04 Jun 2021

Insider Transactions Reported by Joshua A. Kazam:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.